CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation
Asian Journal of Andrology · 2025
DOI: 10.4103/aja202556 ↗Kurz gefasst
Fallbericht in der Zeitschrift Asian Journal of Andrology, 2025. Verfasst von Hua-Yan Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Acrosome, Ciliary Motility Disorders, Infertility, Male, Sperm Tail. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by impaired motility of cilia and flagella. Mutations in cilia- and flagella-associated protein 300 ( CFAP300 ) are associated with human PCD and male infertility; however, the underlying pathogenic mechanisms remain poorly understood. In a consanguineous Chinese family, we identified a homozygous CFAP300 loss-of-function variant (c.304delC) in a proband presenting with classical PCD symptoms and severe sperm abnormalities, including dynein arm deficiency and acrosomal malformation, as confirmed by transmission electron microscopy (TEM). Histological analysis revealed multiple morphological abnormalities of the sperm flagella in CFAP300 -mutant individual, whereas immunofluorescence demonstrated markedly reduced CFAP300 expression in the spermatozoa of the proband. Furthermore, tandem mass tag (TMT)-based quantitative proteomics showed that the CFAP300 mutation reduced key spermatogenesis proteins (e.g., sperm flagellar 2 [SPEF2], solute carrier family 25 member 31 [SLC25A31], and A-kinase anchoring protein 3 [AKAP3]) and mitochondrial ATP synthesis factors (e.g., SLC25A31, cation channel sperm-associated 3 [CATSPER3]). It also triggered abnormal increases in autophagy-related proteins and signaling mediator phosphorylation. These molecular alterations are likely to contribute to progressive deterioration of sperm ultrastructure and function. Notably, successful pregnancy was achieved via intracytoplasmic sperm injection (ICSI) using the proband’s sperm. Overall, this study expands the known CFAP300 mutational spectrum and offers novel mechanistic insights into its role in spermatogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
- NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China.
- Anhui Province Key Laboratory of Reproductive Health and Genetics, Hefei 230032, China.
- The Second Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
- The Second School of Clinical Medicine, Anhui Medical University, Hefei 230032, China.
Zitieren
APA
Yin, H. Y., Zhou, Y. Q., Shen, Q. S., Chen, Z. W., Li, J. R., Wu, H., Cao, Y. X., Guo, R., & Song, B. (2025). CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation. Asian Journal of Andrology. https://doi.org/10.4103/aja202556
Vancouver
Yin HY, Zhou YQ, Shen QS, Chen ZW, Li JR, Wu H, et al. CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation. Asian Journal of Andrology. 2025. doi:10.4103/aja202556
BibTeX
@article{Yin2025,
author = {Yin, Hua-Yan and Zhou, Yu-Qi and Shen, Qun-Shan and Chen, Zi-Wen and Li, Jie-Ru and Wu, Huan and Cao, Yun-Xia and Guo, Rui and Song, Bing},
title = {CFAP300 loss-of-function variant causes primary ciliary dyskinesia and male infertility via disrupting sperm flagellar assembly and acrosome formation},
journal = {Asian Journal of Andrology},
year = {2025},
doi = {10.4103/aja202556}
}
EUVIMED